INTRODUCTION
============

The construction and screening of cDNA libraries is a common technique in the analysis of mRNA transcripts. Sequencing of full-length cDNA clones is an accurate and reliable way to delineate complete gene structures in genomic sequence, including exons and introns, open reading frames (ORFs) and 5′- and 3′-untranslated regions (UTRs) ([@b1],[@b2]). Large collections of cDNAs have been used in functional genomic studies of genes and proteins, including spotted cDNA microarray analysis ([@b3]), yeast two-hybrid protein interaction screening ([@b4],[@b5]), and high-throughput X-ray crystallography ([@b6]). The development of comprehensive non-redundant cDNA collections is an important objective of the human and model organism genome projects ([@b7],[@b8]).

Expressed Sequence Tag (EST) sequencing is an efficient method for obtaining cDNA clones representing a significant fraction of the transcripts encoded in a genome ([@b9]--[@b12]). However, ESTs sample cDNA libraries at random, and the representation of transcripts in cDNA libraries is related to their expression levels in the tissues and developmental stages profiled, so EST sequencing is inefficient at recovering rare transcripts. The use of normalized cDNA libraries can improve the efficiency of gene discovery by EST sequencing, but even the best methods result in very incomplete normalization, so the advantage of this approach is limited ([@b13]--[@b15]). In addition, because ESTs are derived from cDNA ends, they often fail to elucidate alternative splicing in the central regions of transcripts. Thus, to screen cDNA libraries for genes and alternative transcripts that are not represented in large EST collections, efficient directed methods are needed.

As a first step in producing a non-redundant collection of *Drosophila melanogaster* cDNAs, we generated 262 140 5′ EST sequences from directionally cloned cDNA libraries representing a variety of tissues and developmental stages ([@b12],[@b16]). These data represent 19.5-fold over-sampling of the 13 449 protein-coding gene models in the Release 4.1 annotation of the *D.melanogaster* genome sequence (<http://flybase.net/annot/>). The EST data were used to select cDNA clones for full-insert sequencing to create the Drosophila Gene Collection (DGC). Most clones were selected computationally, initially by *inter se* clustering and later by alignment to the genome sequence; some additional clones were selected by human curators during genome annotation (<http://www.fruitfly.org/EST/index.shtml>). Full-insert sequencing of DGC cDNAs ([@b13]) led to major improvements in the annotation of protein-coding genes in the genome sequence ([@b2]). Within the DGC, we distinguish a set of clones encoding protein sequences that perfectly match translated genome sequence annotations; these clones are suitable for functional genomic and proteomic studies (DGC Gold, <http://www.fruitfly.org/EST/gold_collection.shtml>). (Full-length cDNAs that do not match annotated gene models may reveal unannotated protein isoforms and so may also be suitable for functional studies.) The DGC currently comprises 6263 Gold cDNAs and 5266 additional sequenced cDNAs.

Our mapping of ESTs to gene annotations shows that there are 3125 annotated protein-coding genes not yet represented in the DGC. In addition, the genome sequence annotation predicts that ∼20% of *Drosophila* genes produce two or more alternatively spliced transcripts ([@b2]), and this is likely an underestimate. Thus, at least 2500 annotated alternatively spliced protein-coding transcripts are also not yet represented in the DGC. Sequencing of the most recent 10 000 5′ ESTs identified cDNAs for only 96 additional genes (1% yield). Although EST sequencing of new libraries from different tissues and developmental stages might marginally increase the rate at which additional genes are sampled by EST sequencing, an efficient method for directed screening of cDNA libraries to recover clones for specific transcripts would be very useful.

The traditional method for screening a cDNA library for clones representing a gene of interest is hybridization of labeled gene-specific DNA probes to colonies or plaques transferred to a nylon filter \[reviewed in ([@b17])\]. This method is labor and time intensive, especially when the desired clones are rare in the library. It is not an efficient approach for screening libraries on a large scale. A method has been described for screening arrayed cDNA libraries by PCR of pooled clones in a combinatorial scheme ([@b18]). This approach requires arraying of individual clones into microtiter wells and is therefore practical only for abundantly expressed transcripts.

RT--PCR is an attractive alternative approach, because it recovers cDNA sequences for specific genes directly, without library screening. In RT--PCR ([@b19]), first-strand cDNA is used as a template in a PCR with a pair of gene-specific primers at the 5′ and 3′ ends of the transcript of interest. This procedure can generate cDNAs that are as complete as the starting gene model. However, because it recovers only sequences between the two PCR primers, RT--PCR depends on accurate prediction of the 5′ and 3′ ends of the target transcript in order to produce a cDNA with a complete ORF. The output of most gene-finding algorithms is a single ORF prediction per gene with no predicted UTRs, and it is not uncommon for predicted genes to be missing 5′ and 3′ coding sequences ([@b1],[@b2]). Because gene models with complete ORFs are more difficult to predict than is generally appreciated, and because UTRs are very difficult to predict, complete transcripts are typically not captured by RT--PCR. The related Rapid Amplification of cDNA Ends (RACE) ([@b20]) method is a directed approach to identifying 5′ and 3′ coding and UTR sequences, but it produces PCR products representing only part of a transcript. In addition, because only one of the primers in a RACE PCR is gene-specific, successful amplification often requires sequential rounds of PCR with nested primers. In order to reliably produce full-length cDNAs using these methods, transcript ends would need to be defined by 5′ and 3′ RACE experiments before conducting RT--PCR experiments. Thus, there are practical issues that limit the utility of RT--PCR as a high-throughput strategy.

A method for obtaining the 5′ and 3′ ends of a transcript simultaneously has been described in which primary double-stranded cDNA is self-ligated in dilute solution to produce circular molecules without a cloning vector ([@b21]). The circularized cDNA is used as a template for an inverse PCR ([@b22]--[@b24]) using gene-specific primers directed away from one another in the sequence of the target transcript. The resulting PCR products include both the 5′ and 3′ ends of the transcript, which are joined together in inverted orientation at the point of ligation. This approach to characterizing the 5′ and 3′ ends of transcripts ensures that the two ends within a PCR product are derived from the same transcript isoform. The products can be cloned and characterized, but they are rearranged relative to the intact transcript. Thus, the method does not lead directly to intact cDNA clones.

Two related methods for amplifying intact cDNA clones from plasmid libraries, MACH-1 and MACH-2 ([@b25]), have been described. MACH-1, based on the Stratagene QuikChange™ site-directed mutagenesis protocol (<http://www.stratagene.com>), uses a pair of overlapping, oppositely directed, gene-specific primers to amplify cDNA sequences from a plasmid library in a linear amplification reaction. The products are self-annealed to form nicked circles, which are repaired upon transformation into a bacterial host. Because MACH-1 is a linear amplification method, it is not suitable for recovery of rare cDNAs. MACH-2, based on a PCR-based site-directed mutagenesis protocol ([@b26]), uses two separate inverse PCR with different pairs of gene-specific primers to amplify cDNA sequences from a plasmid library. The linear DNA products from the two reactions are size-selected and purified by agarose gel electrophoresis, mixed together, and melted and re-annealed to form hybrid molecules, which are then transformed into bacteria. MACH-2 appears to be effective and suitable for recovery of rare cDNAs. However, because it requires two PCR per target and includes a gel purification step, it is relatively inefficient and not easily adapted for high-throughput screening.

Here, we describe Self-Ligation of Inverse PCR Products (SLIP), a rapid and efficient method for plasmid library screening that can recover full-length cDNAs representing relatively rare and alternatively spliced transcripts of interest. SLIP is similar to but simpler than MACH-2. It requires one pair of gene-specific PCR primers per target and does not require a gel purification step. We describe screens of cDNA libraries used in our *Drosophila* EST projects for clones representing 153 transcription factor genes that were not represented by full-length clones in the DGC. Our results demonstrate that the new method is effective in recovering relatively rare cDNA clones from plasmid libraries, that the full-insert sequences of many of the resulting cDNA clones reveal unannotated coding sequences and UTRs in curated gene models, and that the approach can be applied productively in a high-throughput setting.

MATERIALS AND METHODS
=====================

PCR primer design
-----------------

A single transcript model was selected from the Release 3.1 annotation ([@b2]) for each curated gene in the list of targets. For genes with multiple curated transcript models, the first('RA') model was arbitrarily selected. *Primer3* ([@b27]) (<http://www-genome.wi.mit.edu/genome_software/other/primer3.html>) designs standard PCR primer pairs and can be used to design primers for multiple sequence targets automatically, but it has no explicit inverse PCR primer design feature, so we wrote software to manipulate the transcript sequences.

*Primer3* was developed for the purpose of designing primers for PCR amplification of DNA with primers flanking the region to be amplified. Since the SLIP process requires the PCR primers to abut at their 5′ ends with no overlap and in opposite orientation on the template, it was necessary to computationally rearrange our template sequences to mimic the format required for *primer3*. A separate template sequence was constructed at each base location from position 26 to position 500 in the template sequence, as follows. First, a series of 4 'N's was added to the 3′ terminus of the transcript sequence. Next, the 5′ sequence of the transcript from base 1 to a base in the range from position 26 to position 500 was removed from the 5′ end and attached after the 'N's at the 3′ end. This generated a linear representation of the circular plasmid, with potential PCR primer locations at the ends and flanking the entire sequence to be amplified. This procedure resulted in 475 templates for primer design for each transcript sequence of at least 500 bp. The procedure started at base 26 so that sufficient sequence would be available at the 3′ end of the template for primer design.

Next, each template sequence was run through *primer3* to design a PCR primer pair, with constraints imposed using the adjustable parameters. [Table 1](#tbl1){ref-type="table"} shows the parameter settings that were used for *primer3*. A critical constraint was to fix the PCR product length equal to the length of the template, forcing the program to design a pair of PCR primers that included the 5′ and the 3′ terminal bases of the template sequence. A mis-priming library was also employed to prevent the design of primers complementary to the cDNA vector pOT2. A primer pair design was produced for each iteration of the template sequence that had sequences at the ends that allowed design of primers that met the *primer3* criteria. *Primer3* produces an output file that describes attributes of each primer pair.

All candidate primer pairs in the *primer3* output file were compared to a database of all curated transcripts in the Release 3.1 annotation using *blastn* (*wublast-2.0* with parameters *S* = 50 *Q* = 200). The *blastn* output files were parsed to check that the targeted transcript had the highest *blastn* score and was perfectly aligned over the length of the primer sequences. Next, alignments to other transcripts were analyzed. If there were any gaps in the alignment to non-target transcripts, the primer was not disqualified. If the alignment was shorter than 16 bp, the primer was not disqualified. If the non-target alignment was equal to or longer than 16 bp, then the 18 3′-most bases of the primer sequence were further analyzed. If fewer than 16 bases aligned in the 18 3′-most bases, the primer was not disqualified. If greater than or equal to 16 bases aligned in the 18 3′-most bases, the primer sequence was checked to see if the two most 3′ bases aligned. If so, the primer was rejected. This process resulted in a reduced set of primer pairs from which to select the optimum pair for each transcript.

To select one primer pair for each targeted transcript from the set of all acceptable primers, we calculated an objective function for each primer pair: $$\begin{array}{l}
{W_{\text{tm}}\left| {T_{\text{m}_{\text{avg}}} - T_{m_{\text{opt}}}} \right| + W_{\text{gc}}\left| {\text{GC}_{\text{avg}} - \text{GC}_{\text{opt}}} \right|} \\
{\quad + W_{\text{blast}}\text{~BlastLength} + W_{\Delta\text{tm}}\left| T_{\text{m}} \right|} \\
\end{array}$$ where *T*~m~ is a melting temperature, *W*~tm~ is the weight assigned to the *T*~m~ (0.3), $T_{\text{m}_{\text{avg}}}$ is the average *T*~m~ of the two primers, $T_{m_{\text{opt}}}$ is the optimum *T*~m~, *W*~gc~ is the weight assigned to GC content (0.1), GC~avg~ is the average percent GC content of the primers, GC~opt~ is the optimum GC content, *W*~blast~ is the weight assigned to the *blastn* alignment (0.3), BlastLength is the length of the longest *blastn* alignment to non-target curated genes, *W*~Δtm~ is the weight assigned to the difference in *T*~m~ between the primers (0.3), and Δ*T*~m~ is the difference in *T*~m~ between the two primers. For each targeted gene, we selected the primer pair with the lowest objective function score.

cDNA library screening
----------------------

For each targeted gene, the forward and reverse PCR primers (8 µM each) were phosphorylated in a single 15 µl reaction with T4 polynucleotide kinase (0.25 U) at 37°C for 1 h, followed by heat inactivation of the enzyme at 65°C for 20 min.

Aliquots of the GH (adult head, 1.23 µg/µl), LD (embryo, 1 µg/µl), LP (larva and pupa, 1.16 µg/µl) and SD (S2 cell line, 0.66 µg/µl) plasmid pOT2 cDNA libraries described in ([@b12]) were pooled to make a mixed library stock. Each library was available as a singly amplified stock, and 10 µl aliquots of each were combined to generate the pool. We estimate the complexity of the mixed stock to be ∼2 × 10^6^ independent clones. The mixed stock (1 µg/µl) was diluted 1:500 to produce a working stock for use in PCR.

PCR was conducted with Phusion DNA polymerase (Finnzymes) according to the manufacturer\'s instructions. Each 15 µl reaction included 1.5 µl of working library stock, 1 µM of each 5′-phophorylated primer, 200 µM dNTPs and 0.3 U of polymerase. Reactions were heated to 98°C for 30 s, followed by 35 PCR cycles including denaturation at 98°C for 10 s, annealing for 30 s and extension at 72°C for 2 min, 45 s. The manufacturer\'s suggested extension time for complex templates is 30 s per kb; the pOT2 vector is 1.5 kb in length; thus, the extension time we used is sufficient to amplify cDNAs with inserts at least 4 kb in length. The annealing temperature for the first five cycles was ramped down linearly from 72 to 68°C (touchdown PCR). In the subsequent 30 cycles, the annealing temperature was 68°C. After cycling, the reactions were incubated for an additional 5 min at 72°C to finish the final extension. To exchange the buffer and reduce the concentration of unincorporated dNTPs and primers, each PCR product was diluted to 30 µl with dH~2~0 and subjected to gel filtration through a 300 µl Sepharose G-50 column in 96-well format.

Half of each filtered sample (15 µl) was treated with T4 DNA ligase (400 U, New England BioLabs) in a 100 µl overnight reaction at 16°C. DpnI (20 U, New England BioLabs) was then added to each sample, and the reactions were incubated at 37°C for 2 h and then at 80°C for 20 min to inactivate the restriction enzyme.

An aliquot (2 µl) of each self-ligated and digested sample was transformed into TAM1 chemically competent *Escherichia coli* host cells (Active Motif) in 96-well format according to the manufacturer\'s instructions. The entire volume of transformed cells was plated on LB agar plates containing chloramphenicol (50 µg/ml) and incubated overnight at 37°C. Four clones per target were grown overnight in 2× YT media containing chloramphenicol (50 µg/ml). An aliquot of each culture was used to produce an archival frozen stock, and the remainder was used to prepare plasmid DNA by a standard alkaline lysis procedure.

Plasmid DNA samples were used to produce three sequence reads. Sequencing reactions were performed with BigDye v3.1 dye-terminator chemistry (Applied Biosystems) at 1/16th the manufactures recommended scale. Sequence data were collected on an Applied Biosystems 3730 × 1 capillary device. All templates were sequenced with the primers PM002 (5′ end), PM001 (3′ end) ([@b16]), and the target-specific, sense-strand PCR primer. Following data analysis, selected cDNAs were sequenced to completion using additional custom primers.

Sequence assembly and finishing
-------------------------------

Sequence trace files were processed using *phred* and *crossmatch* to produce vector-masked sequence files with basecalls and associated quality scores ([@b28],[@b29]). The three sequence reads from each template were assembled using a customized version of *phrap* (<http://www.phrap.org>) in which every trace is included in the assembly. Each sequence assembly was evaluated by a custom script in a series of tests to select clones for full-insert sequencing. Test 1, if the translation of the longest ORF in the contig containing the 5′ end read matched the predicted protein sequence of a transcript of the targeted gene, then the cDNA library screening experiment was declared 'done', and the clone was entered into our cDNA sequence finishing pipeline. Our standard cDNA finishing pipeline requires quality standards higher than can routinely be achieved with three traces (*phrap* estimated error rate less than 1/50 000; individual base quality better than q25), so a further round of primer sequencing was performed if needed. This work was designed manually or by *autofinish* ([@b30]). Test 2, if the sequence assembly produced contigs with only a partial match to the predicted transcript or coding sequence (CDS) because of low sequence quality, sequence gaps, or errors in the gene prediction, then the clone was retained for possible full-insert sequencing. A partial match was defined as alignment of at least 50% of the length of the cDNA contig containing the 5′ read. The percent identify of the match was also reported. If the contig sequence did not meet this criterion, all contigs were concatenated together and compared to the annotated transcript using *sim4* ([@b31]). Alignment of 50% of the length of the clone sequence, or 100 bp and a percent identity of 50% over the aligned region, was required for inclusion in the cDNA finishing pipeline. Test 3, if the assembly did not show any significant alignment to the target, the clone was discarded.

After all of the cDNA isolates for a particular target were evaluated, we selected from the set according to the rules: (i) if one or more isolates from a target was 'done', the isolate that had a poly(A) tail, included the longest 5′-UTR, and had the highest sequence quality was selected. If no isolate had a poly(A) tail, we still proceeded with sequence finishing of the isolate with the longest 5′-UTR, if the entire targeted CDS was captured. All other isolates were removed from the processing queues. (ii) if one or more isolates passed Test 2 and no isolates passed Test 1, all candidate isolates were selected for one round of sequencing using custom primers designed to the target gene sequence. If none of the isolates then passed quality standards, one of the isolates was selected for finishing. The isolates selected for finishing were entered into the cDNA processing pipeline for quality assurance, automated annotation and sequence submission. Sequences of 88 cDNA clones reported here were submitted to the GenBank data library; their accession numbers are reported in [Table 4](#tbl4){ref-type="table"}.

Sequence analysis
-----------------

Each finished cDNA sequence was aligned to the genome sequence and the annotated Release 4.1 target transcripts using *sim4*. The highest scoring alignment was recorded, and the corresponding annotated transcript was used for further analysis. Transcript alignments with scores of less than 100% were manually reviewed for nucleotide discrepancies, co-ligation events, retained introns, genomic contaminants and antisense transcripts. The longest predicted ORF was identified in each finished cDNA sequence, and its protein translation was compared to the translated annotated CDS using *sim3* ([@b32]). Alignments with scores of less than 100% amino acid identity were manually reviewed and annotated for N-terminal and C-terminal extensions and truncations of the predicted protein sequence, exon variants, dicistronic transcripts and merges of annotated genes.

RESULTS
=======

cDNA library screens for 153 transcription factor genes
-------------------------------------------------------

The SLIP cDNA library screening method is diagrammed in [Figure 1](#fig1){ref-type="fig"}. cDNA clones representing a gene of interest are amplified from a plasmid library with gene- or transcript-specific PCR primers. The primers are designed to match the sequence of the target exactly, to abut each other without overlapping, and to be oriented in opposite directions as for inverse PCR. The resulting linear PCR products are treated with T4 DNA ligase to circularize them. Thus, the procedure replicates intact cDNA clones that are identical to the clone from which they were amplified. The reaction mixture is treated with the restriction enzyme DpnI to digest the methylated plasmid library template DNA, leaving the un-methylated PCR products intact. (The cDNA library is methylated by the standard library amplification procedure in a *dam+ E.coli* host.) The resulting plasmid cDNA products are transformed into bacteria, and individual clones are isolated and characterized by sequencing. The procedure is similar to the Stratagene ExSite™ site-directed mutagenesis protocol (<http://www.stratagene.com>).

We tested the SLIP method by screening a pool of cDNA libraries for clones representing 153 *Drosophila* transcription factor genes ([Table 2](#tbl2){ref-type="table"}). These targets are *D.melanogaster* curated genes that have been assigned the function attribute 'transcription factor' in the Gene Ontology database ([@b33]) and that were not represented by full-length cDNA clones in the DGC. Twenty-six of the target genes are represented by one or more ESTs in our collection, but the cDNAs that had been previously selected for full-insert sequencing were found to be compromised and so replacement cDNAs were needed. The remaining 127 target genes are not represented by ESTs in our large collection, indicating that they are rare in our cDNA libraries. The Release 4.1 annotated transcripts of the target genes range in length from 171 to 8834 bases with a median of 1398 bases.

Custom scripts were developed to automate PCR primer design for SLIP. To improve the likelihood of recovering full-length cDNAs, primer pairs were restricted to the 5′ most 500 bases of each curated gene model. Aliquots of four plasmid cDNA libraries, all previously used in our EST sequencing projects, were pooled and diluted to produce a template for SLIP screening. Target gene sequences were amplified from the library pool using a standard PCR procedure.

The linear PCR products were circularized and treated with DpnI. The reaction products were cloned, and four cloned isolates per target were analyzed by sequencing. Sequencing reactions were performed using a pair of primers flanking the cloning site in the vector, and the target-specific, sense-strand PCR primer, to produce three reads. The sequence data were analyzed automatically and reviewed manually. A consensus sequence for each clone was assembled and compared to all annotated transcripts of the corresponding target gene. Of the 153 target genes, 92 (60%) yielded one or more gene-specific clones in this initial screen.

The initial library screen failed to yield specific cDNAs for 61 target genes. It also yielded gene-specific but compromised clones for 27 target genes. These clones were compromised in various ways, all previously observed in cDNA libraries, such that they did not represent high-quality, full-length cDNAs (see below). We performed a second library screen on 56 of the 61 target genes for which the initial screen completely failed, and on 13 of the 27 target genes for which the initial screen yielded only compromised clones. In this second screen, we used a 10-fold higher concentration of the cDNA library pool as the template, in an attempt to recover very rare clones. Analysis of the sequence data from the second screen showed that we recovered one or more gene-specific clones for 12 of the 56 targets that failed in the first screen. Furthermore, for the 13 targets that yielded only compromised clones in the first screen, we recovered novel clones for only two targets and identical, compromised clones for ten targets.

Taken together, the two rounds of library screening produced one or more target-specific clones for 104 (68%) of the 153 target genes ([Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). This total includes clones recovered for 85 of the 127 targets that were not represented in our EST collection, and 19 of the 26 targets that were previously represented in our EST data ([Table 4](#tbl4){ref-type="table"}) but not necessarily by ESTs from the libraries used in this screen. As described below, these clones were further characterized to determine which ones represent full-length cDNAs.

The 49 gene targets that failed to yield target-specific clones fall into three classes. For two target genes, all clones failed to yield sequence data. For 16 target genes, all isolates corresponded to genes that were not the intended targets and did not include a complete copy of one or both of the PCR primer sequences. For 31 target genes, the sequences of all isolates included at least one copy of one or both of the PCR primer sequences, but were otherwise unrelated to the target gene.

We examined the library screening results to look for correlations that might predict successful clone recovery. Named genes are more likely to have been studied and validated at the molecular level, so they might be more likely than un-named genes (annotated based on computational results) to yield specific clones in a cDNA library screen. Of the 153 target genes, 79 are named genes and 74 are un-named genes designated only by a CG (Curated Gene) number in the Release 4.1 annotation. At least one target-specific cDNA was recovered for 51 (65%) of the named genes and 53 (72%) of the un-named genes. Because the library screening method is PCR-based, we examined whether the rate of recovery of gene-specific clones was higher for target genes with shorter predicted transcripts. The median lengths of the Release 4.1 annotated transcripts are 1423 bases for the 104 targets for which gene-specific clones were recovered and 1398 bases for the complete set of 153 target genes. Thus, neither attribute of the target genes is correlated with success in library screening.

Full-insert sequencing and characterization of cDNAs
----------------------------------------------------

The sequence data from the 104 genes with target-specific clones were further analyzed to determine which represented full-length cDNAs ([Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). cDNAs for which the initial three sequence reads did not produce a complete, high-quality sequence of the cloned insert were selected for sequence finishing. Finishing reads were produced using custom primers designed from the sequence assembly and the annotated transcript model. If a cDNA was found to be compromised, the complete sequence of the insert was not necessarily determined.

The predicted protein sequence encoded by the longest ORF in the finished sequence of each cDNA clone was compared to the predicted protein sequence in the recently available Release 4.1 genome sequence annotation (<http://flybase.bio.indiana.edu/>). For 43 (28%) of the 153 target genes, the selected cDNA contains a complete ORF that encodes a protein identical to that of the gene model. For 29 (19%) target genes, the cDNA represents a transcript with an ORF that is not identical to that of an annotated transcript and provides evidence that these gene models should be modified. The cDNAs for 15 of these are classified as '5′ extension', '3′ extension', or '5′ short with upstream in-frame stop codon', meaning that the cDNAs encode a protein sequence that varies in the number of terminal amino acids relative to the gene model ([Figure 2A](#fig2){ref-type="fig"}). The cDNA clones for another 12 of these target genes are classified as encoding 'exon variants', meaning that the cDNA encodes a protein sequence that diverges from that of the annotated gene model, indicating differences in the pattern of mRNA splicing. These include four cDNAs that encode alternate amino termini, one that encodes an alternate C-terminus, and seven that encode different amino acids at locations internal to the CDS. Lastly, one cDNA represents a dicistronic transcript containing both *CG17197* and *CG17198*, and another cDNA provides evidence to merge three annotated genes (*CG15781*, *CG15782* and *CG15783*) into one gene with a single, continuous ORF ([Figure 2B](#fig2){ref-type="fig"}). In summary, high-quality, full-length cDNA clones were recovered for 72 (47%) of the 153 target genes. This total includes 11 of the 26 target genes that were represented by ESTs and 61 of the 127 target genes that were not.

For the remaining 32 (21%) genes with one or more target-specific clones, all clones were compromised in various ways (see [Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). For 27 genes, the clones contain well known cDNA library artifacts, including nucleotide discrepancies, truncations of the 5′ and/or 3′ ends, retained introns, genomic clone contaminants, and co-ligated inserts. This set includes three cDNAs with co-ligated inserts that nevertheless include complete ORFs for the target genes; these ORFs are suitable for cloning into expression systems. The set also includes six clones with nucleotide discrepancies that represent full-length cDNAs; these discrepancies could be repaired by site-directed mutagenesis to produce high-quality cDNAs. Artifacts attributable to the SLIP screening procedure itself are present in the clones selected for four target genes. One clone contains just one of the two PCR primer sequences, two clones contain multiple concatenated copies of both primer sequences, and a fourth clone has a 2 bp deletion at the point of ligation where the 5′ ends of the two primers abut. The latter clone is in all other respects a full-length cDNA and could be repaired by site-directed mutagenesis. Finally, one clone corresponds to an antisense transcript and may represent a complete transcript. A number of such cDNAs were documented in the Release 3.1 genome sequence annotation ([@b2]), and the existence of antisense transcripts has been reported in many organisms ([@b34]).

PCR has a bias toward amplification of short products, so we examined the lengths of the cDNAs recovered in our screens. The longest cDNA recovered for which we produced a finished sequence has an insert length of 4415 bp, but it is compromised by co-ligation. The longest full-length, high-quality cDNA recovered has an insert length of 3504 bp and contains an ORF of 2670 bp. The longest ORF in a high-quality, full-length cDNA recovered in our screen is 2961 bp in length. There are nine target genes with annotated CDS lengths greater than 3000 bp for which cDNAs were recovered, and none of these cDNAs encodes the complete ORF: four are 5′ or 3′ short, two are co-ligated and short, one contains a SLIP artifact, one contains a frameshift, and one encodes a full-length version of a shorter exon variant. Thus, the screen failed to recover full-length cDNAs for the longest target genes.

To assess whether SLIP selects for short clones, we compared the results of our directed screen to our EST sequencing results for the same cDNA libraries. In a set of ∼80 000 5′ EST sequences, the fraction that include the predicted start codon of the corresponding gene model in the Release 1 genome sequence annotation was 80% ([@b12]). Because this result is based on 5′ ESTs and not on full-insert cDNA sequences, it does not account for clones truncated at the 3′ end, and thus somewhat overestimates the frequency of full-length clones in the libraries. In the directed library screens reported here, the cDNAs for 72 of the 104 selected target-specific clones contained high-quality, full-length ORFs, another 10 cDNAs are full-length but compromised by nucleotide discrepancy or co-ligation (including one 'SLIP artifact' clone compromised by a 2 bp deletion), and an additional five cDNAs classified as '3′ short' also contain the predicted start codon ([Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). Therefore, 87 (84%) of the cDNAs reported here include the predicted start codon of the Release 4.1 gene model. Thus, similar frequencies of full-length cDNA clones were recovered by 5′ EST sequencing and by SLIP screening.

Finally, we note that *Ada2A* and *Rpb4* were distinct genes in the Release 3.1 annotation but have been merged into a single gene with multiple transcript isoforms in the Release 4.1 annotation. The two screening experiments performed on the *Rpb4/Ada2A* gene, based on the Release 3.1 annotation and with different PCR primers, recovered cDNAs representing different transcript isoforms, and so the two experiments were treated as independent in our analyses.

DISCUSSION
==========

We have demonstrated that SLIP is an efficient and effective method for screening plasmid cDNA libraries. In screens for 153 *Drosophila* transcription factor genes known to be represented at relatively low levels in our cDNA libraries, we recovered high-quality, full-length cDNAs with complete ORFs for 72 genes and compromised cDNAs for another 32 genes. The six cDNAs compromised by nucleotide discrepancies, and one clone with a 2 bp deletion resulting from a SLIP artifact, could be repaired by site-directed mutagenesis to produce high-quality, full-length cDNAs. Three of the co-ligated cDNAs encode complete ORFs suitable for cloning into expression systems. Thus, by a more liberal standard, full-length cDNAs were recovered for 82 genes. SLIP is simpler to perform than the similar MACH-2 method, and both methods are considerably more efficient than the traditional hybridization-based library screening approach.

Because PCR tends to amplify shorter products more efficiently, SLIP likely has a bias toward recovery of shorter clones. Thus, if a cDNA library contained clones of various lengths for a target gene, SLIP might recover only short cDNAs with incomplete ORFs. Many of the short clones in cDNA libraries are missing the 5′ end of the transcript. We took two measures to improve the recovery of full-length clones: we designed PCR primers within the first 500 bases of each annotated transcript model, and we performed PCR with an extension time sufficient to amplify cDNAs with inserts of at least 4 kb in our 1.6 kb cloning vector pOT2. We recovered relatively long full-length cDNA clones, but we did not recover full-length clones for target genes with ORFs longer than 3 kb. Comparison to EST sequencing results from the same cDNA libraries shows that the two approaches recovered full-length cDNAs at a similar rate. This suggests that full-length cDNAs for target genes with long ORFs are rare in the cDNA libraries used in this study. However, we cannot exclude the possibility that some long transcripts were not recovered in our screens due to the PCR conditions used.

Modifications to the SLIP protocol are likely to improve recovery of long cDNAs. Techniques for PCR amplification of large fragments, including increasing the number of cycles of amplification, increasing the extension time and employing DNA polymerases optimized for 'long PCR' could be incorporated to reduce size bias due to the PCR step and recover long cDNAs. PCR amplification of fragments at least 20 kb in length from complex templates such as the human genome is a routine procedure ([@b35]), and kits for this purpose are available from several commercial suppliers. Libraries containing full-length cDNAs for very long transcripts are also necessary for recovery of long cDNAs, and methods for constructing such libraries have been developed ([@b36]). In addition, PCR products could be size-selected by excision from agarose gels before the self-ligation step. Although we have not demonstrated recovery of very long cDNAs using SLIP, we see no reason the method should be significantly limited by the lengths of transcripts or cloning vectors.

The success of SLIP screening was not significantly correlated with named genes, a common surrogate for the confidence of the target gene annotation, nor with the presence of ESTs in our collection. This suggests that recovery of a cDNA clone for a target gene depends primarily on the presence of a cDNA clone in the library. Because we diluted the cDNA library pool 500-fold for the first round of screening experiments, library complexity seemed likely to be a limiting factor. To test this, we performed a second screen for 69 target genes, including 56 targets that failed to yield specific clones in the first round of screening, using a 10-fold higher concentration of library pool (50-fold dilution). An additional twelve genes yielded specific clones in this second screen. The effect of library concentration was not dramatic, however, which suggests that most of the complexity of the library pool was represented in each sample in the initial round of screening. Statistical analysis of the results indicates that the additional successes in the second round of screening are consistent with the expected increase from selection of additional isolates for sequence analysis, with the underlying screening success rate identical for both library dilutions (data not shown). Note that these cDNA libraries had already been extensively sampled by EST sequencing, and this had not yielded clones for 127 of the 153 genes targeted in this study. To use this screening method to recover cDNAs for the transcription factor genes that are still not represented in our collection, new cDNA libraries with higher complexity and from additional tissues and developmental stages would seem to be required.

Since PCR primers were designed based on Release 3.1 annotated genes, including many for which no molecular evidence currently exists, our success in recovering clones depended upon the accuracy of the gene predictions. In 29 cases, the clones recovered in the screen provide evidence that the corresponding gene models should be modified. For three of the failed library screening experiments, the revised Release 4.1 gene models do not include the Release 3.1 exons used to design the PCR primers. This provides a trivial explanation for these failures. Further examination of the PCR primer sequences and the gene models they were designed to target may suggest other ways of improving the success rate.

The 49 genes that did not yield target-specific clones probably failed due to absence of clones from the cDNA library aliquot. Most of the failed screens yielded clones representing genes that were not targets. These non-target clones probably arise by mis-priming during PCR in the absence of target-specific cDNAs. Another potential explanation for the recovery of non-target clones is incomplete DpnI digestion of the library template DNA. However, in many cases the sequence traces from non-target clones include sequences complementary to one or both of the corresponding PCR primers. Thus, mis-priming appears to be the primary failure mode.

Our results suggest ways of optimizing the screening procedure. One of the easily adjusted parameters is the number of isolates selected for sequence analysis. Based on a retrospective analysis, we estimate that by characterizing four isolates per target instead of three, we have increased our screening success rate by ∼12%. Similarly, characterizing four isolates per target yields ∼32% more screening successes than two isolates, and 88% more screening successes than a single isolate. We estimate that selecting more than four isolates will result in a maximum increase of 5% in the number of successes, and this needs to be balanced against the increase in costs of characterizing additional clones. Another parameter that may be adjusted is the number of isolates selected for full-insert sequencing. While in most cases all of the characterized isolates were identical (based on analysis of the three initial sequence reads), there were cases in which different clones were recovered. These may indicate alternative transcription start sites or alternative splicing, rather than incomplete cDNAs. Another area for optimization is in the automated analysis of the initial sequence reads to determine which clones should be considered for full-insert sequencing. Analysis of the finished sequences from these experiments, largely gained through manual examination, suggests that a useful criterion for clone selection would be 50% or greater sequence identity of the clone and the corresponding gene model over at least half the length of the sequence data generated from the clone.

The success of these directed library screens raises the question of when a project to produce a non-redundant cDNA collection should switch from an EST-based approach to a directed approach. At the end of our EST sequencing project, the final 10 000 EST sequences identified cDNAs representing just 96 (1%) new genes not previously represented in the collection. At that point, it was decided that additional EST sequencing was not warranted. If an efficient directed method had been available, we might have switched from EST sequencing to directed library screening at an earlier stage in the DGC project.

In our view, the results described here justify a larger scale SLIP screen for cDNA clones representing the remaining annotated genes and alternative transcripts that are not yet represented by cDNA clones in the DGC. We assert that cDNAs obtained by library screening can be more informative and valuable than RT--PCR products. The principle advantage of cDNAs over RT--PCR products is that cDNAs can recover sequences at the 5′ and 3′ ends of transcripts that are not represented in annotated gene models. In our screens, we recovered full-length cDNA clones that extend the ORF of the annotated gene model in the 5′ (10 genes; e.g. [Figure 2A](#fig2){ref-type="fig"}) or the 3′ (3 genes) direction, that discover a dicistronic transcript (one gene-pair), and that fuse gene models (three gene models into one gene; [Figure 2B](#fig2){ref-type="fig"}). For these 15 genes, RT--PCR experiments based on the ORFs in the annotated gene models would have amplified cDNA products representing incomplete ORFs encoding truncated protein sequences. Furthermore, such RT--PCR data would appear to validate the incomplete gene models. In addition, we recovered five full-length cDNAs classified as exon variants that have alternative 5′- or 3′-terminal coding sequences that are not present in the genome annotation. Because the termini of these ORFs are not present in the current genome annotation, they would not be recovered in annotation-based RT--PCR experiments. The 5′ and 3′ ends of transcripts can be recovered by RACE, but this approach does not lead directly to full-length cDNA clones. Thus, because it involves fewer assumptions based on predicted transcript structures, we consider directed cDNA library screening to be a more conservative and informative approach than RT--PCR.

RT--PCR is likely to be more sensitive than directed cDNA library screening for the recovery of sequences of transcripts with extremely low expression levels because it does not involve library construction steps, which inevitably reduce the complexity of the sample. RT--PCR is also likely to be more effective for recovery of long transcripts, since it constrains amplified transcript sequences to include the 5′ and 3′ ends defined by the PCR primers. Thus, we do not assert that directed cDNA library screening is better than RT--PCR. Instead, we maintain that SLIP can be more informative than RT--PCR and that the two approaches are complementary, each with distinct advantages and disadvantages.

In a pilot study evaluating the use of RT--PCR to generate cDNA clones for the Mammalian Gene Collection, acceptable full-ORF clones were recovered for 67% of 384 well characterized human genes that had sequences in the RefSeq database but that were not yet represented by cDNAs in the collection ([@b37]). In the study, RT--PCR was performed on a series of RNA templates representing different human tissues until a PCR product of the expected size was obtained for each target gene. Multiple bands were observed in many of the RT--PCR, so bands of expected size were purified by excision from agarose gels before cloning. Twelve or more cloned isolates were end sequenced for each target; 4718 clones were sequenced to recover acceptable clones for 259 genes. In our study, the targets include many uncharacterized predicted genes, the cDNA libraries were pooled into a single PCR template, no agarose gel analysis or purification was performed, and four clones were analyzed per target (although 67 targets were subjected to two rounds of screening). The target gene sets, the tissue sampling approaches, and the work expended per target are quite different in the two studies, making their direct comparison difficult.

A productive and rigorous strategy for cloning and characterizing a eukaryotic transcriptome might involve successive phases of EST sequencing, directed cDNA library screening using SLIP, RT--PCR amplification of annotated ORFs and RACE experiments to recover uncaptured UTRs and coding sequences and to precisely define transcription start sites. A strategy based purely on RT--PCR and RACE could also be effective, particularly if advances in genome annotation approaches lead to significant improvements in gene prediction.

Finally, cDNA libraries are often constructed from RNA isolated from particular tissues or developmental stages, so EST and cDNA sequences can provide data on when and where a transcript is expressed. We pooled cDNA libraries into a mixed template to improve the efficiency of our screens, resulting in the loss of this spatial and temporal expression information. In *Drosophila*, large datasets on RNA expression have been produced in microarray studies ([@b38],[@b39]) and embryonic *in situ* hybridization experiments ([@b40]), and these data have much higher resolution and reliability than data from cDNA library associations. If cDNA libraries constructed with library-specific sequence tags were used, as in the rat EST project ([@b41]), then the library source information for cDNAs amplified from a pooled template would be retained.

In summary, SLIP is an effective method for increasing the representation of genes and transcripts in comprehensive cDNA collections, such as those currently under construction by the NIH Mammalian Gene Collection project for several model organisms and the human ([@b7],[@b8]). We have used it to recover full-length cDNA clones for 72 genes with relatively low expression levels. Our results also demonstrate that SLIP can be used to screen for cDNAs representing alternatively spliced transcripts. By designing PCR primers in predicted isoform-specific exonic sequence, cDNAs containing the alternatively spliced sequences can be targeted. Finally, the utility of SLIP is not limited to genomic applications. The method is simple and should be useful in any project requiring the isolation of cDNA clones. The main limitation is the availability of high-quality plasmid cDNA libraries representing organisms, tissues and developmental stages of interest.
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![Description of SLIP. (**A**) A pair of oppositely directed PCR primers is designed within an exon of a target gene. The primers abut at their 5′ end with no overlap, and the 5′ end are phosphorylated. (**B**) The primers are used to amplify specific clones from a plasmid cDNA library. The positions of the primers (arrows) within a target cDNA are shown, with the vector indicated in white and the cloned cDNA insert indicated in black and white cross-hatch. The resulting linear products are complete sequences of target clones, including the intact vector and the entire insert, which is split into two halves at the position of the PCR primers. Self-ligation of the linear PCR products into circular products replicates the original target cDNA clones. The methylation-sensitive restriction enzyme DpnI is used to digest the un-amplified plasmid library DNA, leaving the self-ligated amplification products intact. These products are cloned, sequenced and analyzed as described in the text to identify bona fide target-specific cDNAs.](gni184f1){#fig1}

![cDNA sequences improve gene annotations. (**A**) Comparison of cDNA IP01040 to the targeted Release 4.1 annotated gene model CG10604. Exons (filled boxes), introns (connecting lines), start codons (green) and stop codons (red) are indicated. The positions of the PCR primers used in the SLIP screening experiment are shown (arrows not to scale). The cDNA subsumes the gene model and extends beyond it by 829 bases at the 5′ end, including 5′-UTR sequence and sequences encoding an additional 142 N-terminal amino acids, and by 344 bases at the 3′ end. (**B**) Comparison of cDNA IP01192 to the three corresponding gene models CG14781, CG17782 and CG15783. The positions of the PCR primers within the target gene model CG15782 are indicated. The cDNA shows that the three annotated gene models are parts of one gene with a single long ORF.](gni184f2){#fig2}

###### 

*Primer3* parameter settings

  Parameter                              Setting
  -------------------------------------- -------------------------------------
  Primer length                          23 bases ±2
  Max. number of Ns in primer sequence   0
  Product size                           Full-length of annotated transcript
  *T*~m~                                 65° ±5
  GC clamp                               Most 3′ base must be G or C
  GC content                             50% ±20
  Max. complementarity (self)            8[a](#tf1-1){ref-type="table-fn"}
  Max. complementarity (paired primer)   8[a](#tf1-1){ref-type="table-fn"}
  Max. mononucleotide repeat in primer   5 bases
  Max. end stability                     9[a](#tf1-1){ref-type="table-fn"}

^a^See <http://www-genome.wi.mit.edu/genome_software/other/primer3.html> for score calculation methods.

###### 

Experimental design

  Gene name[a](#tf2-1){ref-type="table-fn"}   Transcript length[b](#tf2-2){ref-type="table-fn"}   Primer 1                    Primer 2
  ------------------------------------------- --------------------------------------------------- --------------------------- ---------------------------
  *Abd-B*\*                                   4743                                                GCGAGAGAGAAAGAGCGTACGAG     TCTCGTGGTTTCCTCCTGACC
  *ac*\*                                      961                                                 GGGAACGCAACCGCGTAAAGC       GGGCATTTCTCCGGATAACAGAG
  *Ada2A*[c](#tf2-3){ref-type="table-fn"}\*   2422                                                GGAACTCCATGGTTTTGTATAATCC   TGGTGTGTTCATTCTGATGTGC
  amos                                        1154                                                AATCGGGTACCTGAGCGGATCG      GCCAACCTCTTGAGGATCAGCAG
  ato                                         1483                                                AACTGCCATTGGTCGTGCCACTC     GGTGGTGAGTTGCAGCGGTCTC
  BBS2                                        1650                                                TGGAGTTCGAGCGTATAGCCACTG    CTTCCTCGGTGGCCTCATTCC
  B-H2                                        3089                                                CCGGAAATGTCCGCAACAACG       TGGCATTGTGGTCATGTGTGG
  bsh                                         1524                                                TCCCACTACAACGGAGATCAG       AGTTCCGTGTCGCGAGTGGTG
  Bteb2                                       962                                                 CCGGACTTAAGTGATTGGGAGCAG    CGGACATACGGTCAGGTCATTG
  btn                                         2332                                                TCACTCTTTCCACTTCACAACATGC   AAACAAAATGAGAGTGTGCAAATG
  C15                                         1105                                                CCATTGAGCGAGTCCCTGCAGTC     CGTTTCGGACTCGTCGTAGCAG
  cato                                        570                                                 CCGGAATGGCAATTCTTGGATG      CGATAAGAAAGCCCCCTGTCC
  Cdk7                                        1392                                                CTAAACGATGCTGCCCAATGC       GAGCCTCATAAATAGCACGAAAATG
  CrebB-17A                                   1080                                                GACCGGGTGCTTGGTGTCAAC       CCCAAATGCTCACCTGCAGTC
  *debcl*\*                                   1626                                                ACTGCCCGTTGAAATTCAGAATAC    GGGGAGAGGGAATCGGCCTAC
  dimm                                        1173                                                GTGCCACCAGACGAACTTCACAG     GACGGACGGGTCGAGAACTTCC
  dmrt11E                                     1134                                                TCGCTGTGTTGTACCTCATGC       GCATGCAAGGGATCGGACTCG
  *dmrt93B*\*                                 978                                                 CAAGAAGCTCTGCACCTACAAGAAC   TGACCCCGCAGCTCTGAAATG
  dmrt99B                                     1533                                                CGCCTTGAAGGGACACAAACG       CTGACCACTCCGTGGTTCCTG
  dys                                         2707                                                ACGAAGGGCGCCTCGAAGATG       CGATTTGTTTGCATCGAATCTTG
  *E*(*bx*)\*                                 8834                                                AAAATTTTCACGGTTGCTTAAATGG   TGCGTCTGTTTAAATGTCACTCTTC
  *E*(*spl*)                                  540                                                 CCGAGCTACGAGGTGATGATGG      CGACAAGTGTTTTCAGGTTGTCC
  E(y)2                                       481                                                 AGATACGCGACACAAGGATGAGC     AAGTCTTGCAAATTACCAAGTTTCC
  E5                                          1575                                                GAGATCGGCTCCACTAAGGGTCAG    GTCGAGGATTCGCCCACAATC
  *Eip74EF*\*                                 5994                                                AGTTTCCGCCGCATTGTAATTG      CATTCAGCAAGTATTCTGCTTTCTC
  eve                                         1468                                                ATCCTTCCTGGTTACCCGGTACTGC   ACCTCGCTCCTGCCAGTTACTTC
  fd3F                                        1083                                                CGGTCACCTGTGGGCCATTTC       GCTCCTTGGGGCGCTTTAACTC
  fd64A                                       1098                                                GGCCTTCTACTACCAGGGCATCG     GGTGAAAACGATCCGCACATCAG
  fd96Ca                                      1119                                                CCGCTCAGCGATATCTACAAG       CAACATTTTCTCCGGCGAACTC
  fd96Cb                                      825                                                 TGGCCTTCGATATGTTCGAGAATG    TGGGATGAAGTGTCCAGTAGGAG
  Fer2                                        840                                                 CCAGCAGCATTATATGCAACATAGC   ATGTGACGCAGGTTGTTGGAG
  ftz                                         1758                                                TGTACAACATGTATCACCCCCACAG   TGTTCATGTTGTCGGCGTAGCTG
  gcm2                                        2924                                                GGGCTTTCGAATCGCGGAAAAC      TGCGAACAGGCAACACTTGAG
  gsb                                         1452                                                AGCTGGAGTCCGTCCCTGTGTC      GCTGCCATCTCCACGATTTGG
  H15                                         2555                                                GACCGCAAATACGGGCGTAAAG      TCCGGTTTTTCGTGCTATTTATC
  ham                                         3327                                                ACATGCAGCGAGTGGCACCAG       CCTTGGACGCACAGGACATCTG
  *hang*\*                                    7002                                                AGGAAACCCAAGAGCGAAACTCC     TTATCTTCGCCTATTTTTCCACTTC
  hbn                                         1802                                                AAAAACCAACTTGTAGCAAGTGAAG   TCTTATTTTGTTAGCGATTTTCCAG
  Her                                         450                                                 CCCAATTGATTGCTATTGGAGTGG    CTCTGATATACTCCGGATGTAGGC
  HGTX\*                                      3049                                                CATATAGCCTGATCTCGTTCAAATC   GGTAACTCCGTGGCCGGAAAATATC
  HLH3B                                       1353                                                CCGGGCACCTGAACGGTAATG       ATCGCGGTGACTCGTTGGTCTG
  HLH4C                                       1424                                                ACCGAAATCAGTGGTGCAAATAGC    GCTGGACACTGGACTTTCTTGC
  HLH54F                                      1066                                                GATGCCAGTTCTCAAAGCTCCCAAC   CTCATCGAAGTCGTCATCAAAGAAC
  HLHm7                                       723                                                 CTCCGCAAGCTGAAAGAGTCTAAG    ATGCTGCACGGTGACTTCCAG
  HLHmdelta                                   1016                                                ACAATGGCCGTTCAGGGTCAG       GTATAATGGGTTTTGATTTGGTGTG
  HLHmgamma                                   842                                                 CTGGAACTTACCGTCACCCATTTGC   GATATCGGCTTTCTCCAAACG
  Hmx                                         792                                                 GATGGCAACTCGAAGAGAAAGAAG    ACCATGTGGCGAGGAGCTGTC
  lbe                                         2045                                                GTCAGTATCGTCAGTACCGACTTG    AAGCCTTGTACACTCAAATCTTGC
  lbl                                         1847                                                CCGTAAGGATACAGCCAGGATGTGC   CTTAGCTCCAAACTCTTTTCTACGG
  nau                                         1534                                                CGTACGGTCCGCAAATCGAAGTC     CGAGTGTGTGTACCGCCTTCC
  nerfin-2                                    2088                                                AGTGTCGGGCATTACCAGCAATC     CGACGAAGTGAGTGGTGTCTGG
  Neu2                                        1149                                                TCCAACACCATATGCAAGTCCTG     CAGTGGATCGTGCTTCTCAAC
  nht                                         780                                                 GCAAGGCAAAAGTCTCCATAAAG     TTGCATCCTGAGAGCCTGAGTC
  OdsH                                        1226                                                GCCCCAAATCCGGAAATTAGTC      ATCCATGGACAAGTTGAGAACG
  org-1                                       2100                                                TGCTATGGCAACGACTACTGG       GTTGTAGTCCGTTAGGCTGGTGTC
  Poxn                                        2178                                                GCCTGAGACTGAGCATCCTAATAGC   CCAAATGGCGTTGCTCGAACTG
  Rfx                                         3943                                                ACCCAGAAGATGTCAACAGTCGTG    TTCGCCTGGTCAGCTCTTTAC
  rn                                          3661                                                TCGTTCGTTGTAACGCCCTACC      GGGGTACGAGCGGAACTGGTG
  ro                                          1241                                                CATAGCGAACACTACGATTCTATCC   GGATCTAAGCTGTCACTCCTTTTG
  *Rpb4*[c](#tf2-3){ref-type="table-fn"}\*    2422                                                TGAGGAGCTGCGCCAAATACTCG     TCCTCGAAGCGACCCTCTAGTGAAG
  sc                                          1422                                                CGGCTCCATATAATGTAGACCAATC   GCGAGGAACCAGGCGATAGAG
  sens                                        2450                                                GATTTGTGCAGTGAACAGTATTGAG   TCACTTTCTTGGCGTTGTGATCTTG
  *side*\*                                    2820                                                GATTTGGGCTGTCGGCTTCAC       GTTTTCCCATTGTCCGGGCATC
  sisA                                        768                                                 CCGCACTATCGACAGCATCGTC      GTGAACTGCTTCCGCGATACG
  slou                                        2778                                                ACAGGCACACAACACGGCACATC     GGCAAGTCAATAGCTAAATGCTG
  Sox100B                                     1945                                                CTGAAAGCCGAGCAGAAGAAGG      GGCATAGTTTGCCAAAACCAG
  *Sox14*\*                                   3159                                                CAGGACACGGAGAACAAATAAGTCC   GCCAATCTACACTAAACATCGATTC
  Sox15                                       3654                                                GCGCTATCCGCTGTTTGTATCTTG    TCTTGGGAAAATGAAAATTCACG
  Sox21a                                      1167                                                TAGGCTCTGGATCGGGAAACAC      CTCCCACACTCATACCCATGC
  Su(z)2                                      6313                                                ACCTGCAAAACACGCACAACAC      GCATCTTTCTGCCTATTCTATCTGC
  sv                                          4690                                                AGAGCACGATTCCCAACATCTGC     AGCTGGCCTGTACTTGTATTAAGG
  TfIIA-S-2                                   462                                                 CTGGGCAGAACGCTCCAGGAC       CGTTGTGGCCCTGTAATGTTGATAG
  TfIIEbeta                                   1052                                                ACCGCCGCCTAGCGATGATTC       GGAGCTGGTCTATCGGGCTTG
  Tj                                          1530                                                GTGAAGCGCGAGGATCACAGTC      ATGGCCCAAAGTCGTGACCTG
  tll                                         1938                                                AATTCAATTTGTGCAAGCGTTTC     TCACTTGGCACTGGTGTATCTTTG
  *tun*\*                                     8413                                                GCTGCAAATCAAATTGTCACGTTTC   AGCTGTGGTTGGGCCATCTTC
  vnd                                         3036                                                TTTAAGTTGCCCTACCAGGATACC    TTCCAGACATAGTTCGATTTAGGC
  zen                                         1272                                                CGATGTTAACCCCATCGGTCTG      TGATGATGACCATAGATCAAATCAC
  zen2                                        942                                                 TTTCTGTCGGGATCGACTGTCGTG    CAGTTAGAAAACGCTCCTGCGTATC
  CG10147                                     1347                                                GAAGTTCCACTCCTTCCGAGCAC     TCCAGAAGCTCGTAGCACTCC
  CG10309                                     2778                                                AGGGACGCGCCAAGAATCTGAG      CGGGTGAGTAGATGTTCGTCTTG
  CG10348                                     1593                                                AAGCGGAGAAGCAGTTTCGATCAG    GCCCTTGGCATGGTGATTTAAG
  CG10431                                     2151                                                TCGGAAGATGACTCCATGAGTGG     AACCCTAATTGATGGCACAGC
  CG10887                                     2031                                                TTCACTCAACAGCAAATAGTGTTCC   AAGAATGTGAACGGCTTTGGTG
  CG11072                                     171                                                 CACATCCATCAGAGCCCATAAG      CCCTCTGAACAAACTAGTGTGACG
  CG11085                                     828                                                 ATAGACATTGAGGATCGATCTACGC   ATCCGAATCGTCGTTGGAGAGC
  CG11152                                     1800                                                GACTTTGGAACAATACCGCCTCCAG   ATCGTCGTTGATTGAGCTTGTGAAG
  CG11294                                     946                                                 GATCTGCTCACGGAGTATATGTTTG   GCCGGGCAGCGGTGATATAAAAG
  CG11762                                     957                                                 GGTGGATTTGGACGATGTTCCTG     AATCTTAGTCCGCTTATCATGTGC
  CG11966                                     1764                                                CAACTACATGCAGAGTGCCTATCAC   TTGTTGCTCTCATCCGGCAGTC
  CG12029                                     503                                                 CGTTACAACCGCCGAAATAATCC     CACCGTTCGTACGCTCATCAAAC
  CG13287                                     1386                                                CACCGGGTGGAAAGACCACTC       GCGATGTGGGTGTCTCATTGTTG
  CG13296                                     1398                                                GCATGACCACTTCATCGACAGAAAC   TGGTCGGTGTGATACTGGTGCTC
  CG1379                                      1107                                                GGAAACCTGACACTGGGTGATTC     GCATCCGATTAGGTCATCAATCTC
  CG15258                                     591                                                 CAAAATCGCATAACGCAGGAG       CTGGATCGACCGGATGTGTTC
  CG15269                                     1764                                                AAGGAGCGTAAATCCGCTCAGG      GCCCAGAATCTTACTGATGCTAAAG
  CG15336                                     546                                                 ATCGGACGCGCATCTATTGGAATC    AGCCGCAGAACTCGCACATAAG
  CG15398                                     885                                                 AGGGAGCCGAGGAAATGTCTTTGC    CACTTGCTTTGTTCGCCAGGACTTG
  CG15455                                     921                                                 TCTACCGATCGCCTTCAAGGTTTTG   GTTTTGTTTGAGCGCCAGTGC
  CG15696                                     540                                                 CCACCCAGCATCTTATGTCTCAAAG   GCGTACGGATGGAAAGGCAAG
  CG15710                                     798                                                 CCTGTTTGCAGCCGATAAAAGAG     GCGCCACGTACACCTTGGTAAC
  CG15782                                     455                                                 TGTCTATGCCCGCGAAATGCTC      TCGGGATAATGGGCTTCCTTG
  CG1663                                      1164                                                GGCGGAGGTACAGGAATCTTTC      AACTTGGATTCCTGAGCAATAGAC
  CG16779                                     5943                                                CCGGAAATGTTGGCAGATGTC       ATCCGGATACCCGATGGTCAG
  CG16899                                     1074                                                TTCTTGCGGTCGAAGGATAATGAG    TCTCTCTGCATCGGAGAACATGAG
  CG17075                                     2907                                                AAGTCCCGCAAAGGGAGTAGTGAC    TCGCTGTGCGACTCCGTCAAG
  CG17186                                     1146                                                CTCGTGCAACGTCTGCGGCTAC      AACAGTGACGATTCCACCTCAGAC
  CG17195                                     737                                                 TGCATTTTGAGACGGGACCAC       GGTGTTGCACAAAACGCAGTG
  CG17196                                     831                                                 TGGCCTGCTACCGTACAAGCTCAG    GCAAGTTTCCCAGGATATTGTATG
  CG17197                                     951                                                 AGTACTTGGCGCGTCGAAATC       TGGTGCAGGCCCATATCAAAC
  CG17198                                     873                                                 CAGTTTTTGGGATTGTTTGGACAG    TGGCATTACGTAGAAAGCTTCG
  CG17287                                     1017                                                CGGTGCATTTTCGTAGCTCCAG      AAACCATGTCCATAGAAACATGAAC
  CG17328                                     1413                                                TTTTTAAAACCGATGGCCTACCTTC   CTCTTATTTTAGCGCATTGCATC
  CG17385                                     837                                                 AGACGGTGGCCAATCAGTTCAG      CGTCGAATTCTACCTCCATGC
  CG17568                                     1509                                                ATTAGCGAACTAATCGATTTTGCAG   AAGCGTATAGCACTCCGTACACAGC
  CG17801                                     1054                                                GCCGCGTCATATTTGCCCATC       TGGCGTTCATTCTGTTCTAACC
  CG17803                                     1401                                                AGACGACGGAAAAGTACAACATTC    GCCTAAGCTTTTTGTCGACCTG
  CG18476\*                                   2954                                                ATCAATCTGGATGCAACTGGTAGTC   TTCGGTTAGCTCGCATAAAATCTCC
  CG2120                                      1035                                                CGATCTATTGGAACTTGTGAATGG    TATTCCGAGCCCGGATTCAGC
  CG30417                                     807                                                 CAACTGCTGGGCCTCCACGATTAC    CGGATCCAGTGGCTCGTAGAAAAC
  CG30431\*                                   1810                                                TCGTCCGTATAGATCGGGGCTTC     TTGGCATAGTTGTTTTCCTTGC
  CG30443\*                                   1771                                                GGAGACTACCCCGAACCTCCAC      TCGGCCTGGTTGGACGATGAC
  CG31224\*                                   7059                                                CAAAGCGGAAGACGAGAGGAAAG     TGCGCTCCTTCTTCCAATATACAAG
  CG31241\*                                   2020                                                GCGCCCAAGTACTGCTACTTCTTC    TCTCGAGGTAGAGGCTTCTGG
  CG31612\*                                   3308                                                ATGTTTCGGCGACGCTTATCAGTAG   GAGTGTCAGCAGAGATTCTTGTTCG
  CG31632\*                                   3371                                                AAAATGCAAGCCACTTCCGGTCAG    GGCCACGTCCATAACGGTTTTATC
  CG32532\*                                   4422                                                GCTGGAAAATTTCAATGGAGCGAAG   GGGGGCGTCCTTTCCTGATTTC
  CG32611\*                                   3313                                                TTGCCGAGCTGCAAACCTTAG       AACGGACGTCCTTCAATATCAC
  CG32705\*                                   4705                                                TGTCCGTGGGTGAACAACTGC       GTGATGATCGAAGGTCTCTATGC
  CG32767\*                                   7670                                                CGCAACAGATCGAATTTATACTGC    ATAGGGCGCTATCGTTAATGG
  CG32772\*                                   2476                                                CTCCGAAGACGTGGATCTGATATTC   TCGTCCTGCGACTGTAGGTTCTC
  CG3485                                      993                                                 GATCTCTGAATGCACGGACTGTGAC   ACTTGTGCTATTGAAACCAGCAG
  CG40351\*                                   5846                                                AGACCCGTCCTATCCAACAATAAC    CCTGGCATTAAACCATCGTAAC
  CG4318                                      699                                                 ATCCTTTTCCCAAGACCATTTGC     CCTTCGGTAGAACCGGGAAGC
  CG4328                                      1593                                                GCCGGAGTAGCCCACAATGAC       TTTGGTACTCGCACTCCTTCC
  CG4374                                      2577                                                CGAGTTTTGGCACCAGGACAAG      TAGCCCTGTAACGTGGGATCG
  CG4565                                      672                                                 AATTCTGTTCTTTTGAACCCCTGTC   GTACTCGTCCGCCAAGAATTTG
  CG4575                                      285                                                 GAAGAATATGGAGGCCTTTCAAAC    CGTATCGCGCCCACTTTGACG
  CG4676                                      1008                                                CTTTGCAGCACTGTCTCAGTTGG     CGATTTTTGGCTCTGCTGCTAAC
  CG4956                                      858                                                 AGTTGCATTGGCCATAAAAATCAG    GGCAAAGAAGGTGCAGTGGTG
  CG5245                                      1506                                                AGTTAAAGGCGTCCCGTCGAAGC     GGCTCCAAATCTTTGCCATAACTAC
  CG5369                                      846                                                 TATCCGAGAGCAATACGATCCTC     CGGATAGGTCGGTAATGTCTATGTC
  CG6118                                      2832                                                TCGAAGATCATCAAGAAGTGGAAC    CAGTGGAAGCGGCACATTGAG
  CG7056                                      819                                                 CGCTGCGCTTCAATCCCATCTAC     AAGTGGGAGCCAGGACAGCAC
  CG7368                                      1593                                                TCCGCTGGTTTCCACCGTGAC       GCTGTGCTCGTCGTGAATTGC
  CG7691                                      852                                                 ATTGGCGACAGGGCGACGATATAC    CGCCGCTCGGTTCACTTTGAC
  CG7786                                      579                                                 CCATTCCCCAGAATCTTCGGCTAAC   AAATGGAGTAGGACGGATTGTTC
  CG7963                                      966                                                 CCTTGCAGCCAATGTATTTATGC     TACACAGGTCCACTTGCATCTCC
  CG8089                                      1875                                                GTGCTGTCGAGGATTCAGGGAGAAG   TTGCACTTGCAGTGGCAGGAAG
  CG8117                                      489                                                 GCGACTTGAACGGCTGCAAGG       CGTAAATTGCGTCCTCCAGTTTAG
  CG9571                                      783                                                 TCCATCCGATCGCTGCTCTCC       GAAGCTGGACTGGAAGATTGGTG
  CG9793                                      1041                                                TTGGAAGTCCAAAGGGAGTTGCTC    ACAGCGTTCCCTAAAGGATATGG
  CG9895                                      1233                                                TACAGGTTAAATGGATCACGACTGC   CTCTGCGCTCCAGACGACGAC

^a^Genes represented in our EST collection are indicated by asterisks.

^b^Release 4.1 annotated transcript lengths in nucleotides are reported. For genes with multiple annotated transcripts, the length of the longest is reported.

^c^*Rpb4* and *Ada2A* were separate gene annotations in Release 3.1 but are merged into one in Release 4.1.

###### 

Summary of cDNA clones recovered

  Classification                                                     Clone count[a](#tf3-1){ref-type="table-fn"}
  ------------------------------------------------------------------ ---------------------------------------------
  ORF identical to gene annotation[b](#tf3-2){ref-type="table-fn"}   43
  ORF alters gene annotation[c](#tf3-3){ref-type="table-fn"}:        
      5′ extension                                                   10
      3′ extension                                                   3
      5′ short with upstream in-frame stop codon                     2
      Exon variant                                                   12
      Dicistronic                                                    1
      Gene merge                                                     1
  Subtotal: high-quality, full-length cDNAs                          72
  Compromised clones:                                                
      Nucleotide discrepancy[d](#tf3-4){ref-type="table-fn"}         6
      Short[e](#tf3-5){ref-type="table-fn"}                          
          5′ short                                                   1
          3′ short                                                   5
          5′and 3′ short                                             1
      Co-ligated insert[f](#tf3-6){ref-type="table-fn"}              7
      Antisense transcript[g](#tf3-7){ref-type="table-fn"}           1
      Genomic contaminant[h](#tf3-8){ref-type="table-fn"}            4
      Retained intron[i](#tf3-9){ref-type="table-fn"}                3
      SLIP artifact                                                  4
  Subtotal: compromised cDNAs                                        32
  Gene-specific clones recovered                                     104

^a^One cDNA clone was selected per target gene.

^b^The clone encodes a protein that is identical to the corresponding Release 4.1 annotation.

^c^These clones encode proteins that differ from their corresponding annotation. '5′ extension' and '3′ extension' clones encode additional N-terminal and C-terminal residues, respectively, relative to the annotation. '5′ short with upstream in-frame stop codon' clones encode full-length ORFs that are missing sequences encoding N-terminal residues relative to the annotation and may represent alternatively spliced products. 'Exon variant' clones contain sequence differences relative to the annotation at internal positions in the CDS and represent alternatively spliced products.

^d^The sequence of these clones have nucleotide differences, most likely the result of errors generated by reverse transcriptase during library construction, that introduce a missense or frameshift change in the ORF relative to the annotated CDS.

^e^These clones are missing sequences encoding the N-terminal portion of the predicted protein sequence of the annotation for the '5′ short' class, the C-terminal portion for the '3′ short' class, or both for the '5′ and 3′ short' class.

^f^These clones contain sequences from two unrelated genes and are almost certainly the result of two cDNA molecules being cloned into the same plasmid vector during library construction. In three such cases, the clones encode proteins that are identical to the targeted annotation.

^g^The sequence of the clone overlaps the annotated gene model but is transcribed from the opposite strand.

^h^These clones do not include a poly-adenylated tail. These are genomic clones that contaminate the cDNA libraries.

^i^These clones are poly-adenylated and include unprocessed intron.

###### 

Summary of selected cDNA clones

  Gene name[a](#tf4-1){ref-type="table-fn"}   Clone ID[b](#tf4-2){ref-type="table-fn"}   GenBank accession nos[c](#tf4-3){ref-type="table-fn"}   Classification[d](#tf4-4){ref-type="table-fn"}   Annotated transcript length[e](#tf4-5){ref-type="table-fn"}   cDNA insert length[f](#tf4-6){ref-type="table-fn"}   Annotated CDS length[e](#tf4-5){ref-type="table-fn"}   cDNA ORF length[f](#tf4-6){ref-type="table-fn"}
  ------------------------------------------- ------------------------------------------ ------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------------- ---------------------------------------------------- ------------------------------------------------------ -------------------------------------------------
  *ac*\*                                      IP01413                                    [BT022154](BT022154)                                    match                                            961                                                           962                                                  603                                                    603
  *Ada2A*[g](#tf4-7){ref-type="table-fn"}\*   IP01330                                    [BT022166](BT022166)                                    n.d., S268P                                      2317                                                          2147                                                 1581                                                   1581
  B-H2                                        IP01479                                    [BT022144](BT022144)                                    match                                            3089                                                          3034                                                 1935                                                   1935
  bsh                                         IP01040                                    [BT022203](BT022203)                                    5′ extension                                     1524                                                          2034                                                 1281                                                   1287
  btn                                         NC                                         N/A                                                     co-ligated                                       2332                                                          N/A                                                  474                                                    N/A
  C15                                         IP08859                                    [BT022127](BT022127)                                    n.d., S113I                                      1105                                                          1880                                                 1017                                                   1017
  Cdk7                                        IP01401                                    [BT022155](BT022155)                                    match                                            1392                                                          1457                                                 1059                                                   1059
  *debcl*\*                                   IP01389                                    [BT022157](BT022157)                                    match                                            1626                                                          1743                                                 900                                                    900
  dmrt11E                                     NC                                         N/A                                                     genomic                                          1134                                                          N/A                                                  1131                                                   N/A
  dmrt99B                                     IP01169                                    [BT022192](BT022192)                                    match                                            1533                                                          2343                                                 1530                                                   1530
  dys                                         IP08837                                    [BT022132](BT022132)                                    3′ extension                                     2707                                                          3484                                                 2643                                                   2655
  *E*(*bx*)\*                                 IP08836                                    [BT022131](BT022131)                                    3′ short                                         7830                                                          2631                                                 6477                                                   2110
  e(y)2                                       IP01143                                    [BT022196](BT022196)                                    match                                            481                                                           468                                                  303                                                    303
  eve                                         NC                                         N/A                                                     SLIP artifact                                    1468                                                          N/A                                                  1128                                                   N/A
  Fer2                                        NC                                         N/A                                                     SLIP artifact                                    840                                                           N/A                                                  837                                                    N/A
  ftz                                         IP01266                                    [BT022173](BT022173)                                    match                                            1758                                                          1758                                                 1230                                                   1230
  gcm2                                        IP01423                                    [BT022152](BT022152)                                    match                                            2415                                                          2257                                                 1818                                                   1818
  gsb                                         IP01408                                    [BT022156](BT022156)                                    match                                            1452                                                          1652                                                 1281                                                   1281
  H15                                         IP01538                                    [BT022140](BT022140)                                    match                                            2555                                                          2606                                                 1980                                                   1980
  *hang*\*                                    NC                                         N/A                                                     3′ short                                         7002                                                          N/A                                                  5877                                                   N/A
  hbn                                         IP01393                                    [BT022158](BT022158)                                    match                                            1802                                                          1790                                                 1227                                                   1227
  Her                                         IP01491                                    [BT022141](BT022141)                                    match                                            450                                                           631                                                  447                                                    447
  HGTX\*                                      IP01125                                    [BT022198](BT022198)                                    match                                            3049                                                          3229                                                 1539                                                   1539
  HLH3B                                       IP01280                                    [BT022174](BT022174)                                    match                                            1353                                                          1434                                                 1128                                                   1128
  HLH4C                                       IP01307                                    [BT022167](BT022167)                                    match                                            1424                                                          1456                                                 501                                                    501
  HLHm7                                       IP09063                                    [BT022121](BT022121)                                    co-ligated                                       723                                                           1061                                                 558                                                    558
  HLHmdelta                                   IP01594                                    [BT022133](BT022133)                                    match                                            1016                                                          1017                                                 519                                                    519
  HLHmgamma                                   IP08862                                    [BT022125](BT022125)                                    match                                            842                                                           959                                                  615                                                    615
  lbl                                         IP08853                                    [BT022129](BT022129)                                    exon variant                                     1847                                                          1752                                                 1116                                                   882
  nau                                         IP01012                                    [BT022208](BT022208)                                    exon variant                                     1534                                                          1450                                                 996                                                    984
  nht                                         IP01149                                    [BT022194](BT022194)                                    exon variant                                     780                                                           966                                                  777                                                    735
  OdsH                                        IP01524                                    [BT022139](BT022139)                                    match                                            1226                                                          1310                                                 1146                                                   1146
  Poxn                                        IP01592                                    [BT022136](BT022136)                                    match                                            2178                                                          2468                                                 1275                                                   1275
  Rfx                                         NC                                         N/A                                                     3′ short                                         3943                                                          N/A                                                  2691                                                   N/A
  rn                                          IP01358                                    [BT022161](BT022161)                                    exon variant                                     3661                                                          3118                                                 2838                                                   1626
  ro                                          IP01518                                    [BT022142](BT022142)                                    match                                            1241                                                          1202                                                 1050                                                   1050
  *Rpb4*[g](#tf4-7){ref-type="table-fn"}\*    IP01323                                    [BT022168](BT022168)                                    exon variant                                     732                                                           609                                                  450                                                    417
  sc                                          IP01419                                    [BT022151](BT022151)                                    match                                            1422                                                          1432                                                 1035                                                   1035
  sens                                        IP01345                                    [BT022164](BT022164)                                    match                                            2450                                                          2461                                                 1623                                                   1623
  sisA                                        IP01195                                    [BT022187](BT022187)                                    match                                            768                                                           770                                                  567                                                    567
  *Sox14*\*                                   NC                                         N/A                                                     genomic                                          3159                                                          N/A                                                  2007                                                   N/A
  Sox15                                       IP09065                                    [BT022122](BT022122)                                    n.d., P319L                                      3654                                                          3638                                                 2352                                                   2352
  Sox21a                                      IP01552                                    [BT022137](BT022137)                                    co-ligated                                       1167                                                          2993                                                 1164                                                   1164
  Su(z)2                                      IP01427                                    [BT022149](BT022149)                                    co-ligated                                       6313                                                          2218                                                 4104                                                   1806
  sv                                          IP01047                                    [BT022204](BT022204)                                    exon variant                                     4690                                                          920                                                  2382                                                   537
  TfIIA-S-2                                   IP09007                                    [BT022123](BT022123)                                    co-ligated                                       2917                                                          4415                                                 1527                                                   1527
  TfIIEbeta                                   IP01109                                    [BT022197](BT022197)                                    match                                            1052                                                          1022                                                 876                                                    876
  tj                                          NC                                         N/A                                                     genomic                                          1530                                                          N/A                                                  1527                                                   N/A
  tll                                         IP01133                                    [BT022195](BT022195)                                    match                                            1938                                                          1942                                                 1356                                                   1356
  *tun*\*                                     IP01285                                    [BT022171](BT022171)                                    exon variant                                     4114                                                          3504                                                 3282                                                   2670
  zen                                         NC                                         N/A                                                     SLIP artifact                                    1272                                                          N/A                                                  1059                                                   N/A
  CG10147                                     IP01005                                    [BT022207](BT022207)                                    match                                            1347                                                          1792                                                 1344                                                   1344
  CG10309                                     IP01015                                    [BT022205](BT022205)                                    exon variant                                     2778                                                          3308                                                 2775                                                   2772
  CG10348                                     IP08802                                    [BT022134](BT022134)                                    5′ extension                                     1593                                                          2054                                                 1590                                                   1629
  CG10431                                     IP01025                                    [BT022206](BT022206)                                    5′ extension                                     2151                                                          3382                                                 2148                                                   2352
  CG11085                                     IP01054                                    [BT022201](BT022201)                                    exon variant                                     828                                                           1576                                                 825                                                    885
  CG11152                                     IP01059                                    [BT022202](BT022202)                                    match                                            1800                                                          2320                                                 1797                                                   1797
  CG11294                                     IP01065                                    [BT022199](BT022199)                                    match                                            946                                                           1021                                                 783                                                    783
  CG12029                                     IP01101                                    [BT022200](BT022200)                                    5′ extension                                     503                                                           3021                                                 327                                                    2253
  CG13287                                     NC                                         N/A                                                     3′ short                                         1386                                                          N/A                                                  1383                                                   N/A
  CG15258                                     IP01147                                    [BT022193](BT022193)                                    match                                            591                                                           702                                                  588                                                    588
  CG15336                                     IP01157                                    [BT022191](BT022191)                                    antisense                                        546                                                           705                                                  543                                                    318
  CG15710                                     IP01184                                    [BT022189](BT022189)                                    match                                            798                                                           932                                                  795                                                    795
  CG15782                                     IP01192                                    [BT022190](BT022190)                                    gene merge                                       455                                                           2383                                                 426                                                    1920
  CG1663                                      IP01201                                    [BT022188](BT022188)                                    match                                            1164                                                          1411                                                 1161                                                   1161
  CG16779                                     NC                                         N/A                                                     co-ligated                                       5943                                                          N/A                                                  5940                                                   N/A
  CG16899                                     IP01211                                    [BT022185](BT022185)                                    exon variant                                     1074                                                          1928                                                 1071                                                   1326
  CG17186                                     IP01220                                    [BT022186](BT022186)                                    match                                            1146                                                          1433                                                 1143                                                   1143
  CG17195                                     IP01224                                    [BT022183](BT022183)                                    5′ extension                                     737                                                           942                                                  723                                                    849
  CG17196                                     IP01227                                    [BT022184](BT022184)                                    5′ short, u.s.                                   831                                                           890                                                  828                                                    495
  CG17197                                     IP01230                                    [BT022181](BT022181)                                    dicistronic                                      951                                                           1656                                                 948                                                    870
  CG17198                                     IP01235                                    [BT022182](BT022182)                                    5′ extension                                     873                                                           1087                                                 858                                                    897
  CG17287                                     IP01239                                    [BT022179](BT022179)                                    5′ extension                                     1017                                                          1801                                                 1014                                                   1080
  CG17328                                     IP01243                                    [BT022180](BT022180)                                    match                                            1413                                                          1480                                                 1239                                                   1239
  CG17385                                     IP01247                                    [BT022177](BT022177)                                    match                                            837                                                           1192                                                 834                                                    834
  CG17568                                     IP01252                                    [BT022178](BT022178)                                    3′ extension                                     1509                                                          1856                                                 1506                                                   1539
  CG17801                                     NC                                         N/A                                                     5′ & 3′ short                                    1054                                                          N/A                                                  1035                                                   N/A
  CG17803                                     IP01257                                    [BT022175](BT022175)                                    5′ extension                                     1401                                                          2038                                                 1329                                                   1761
  CG18476\*                                   IP01261                                    [BT022176](BT022176)                                    match                                            2954                                                          2982                                                 2808                                                   2808
  CG2120                                      NC                                         N/A                                                     genomic                                          1035                                                          N/A                                                  1032                                                   N/A
  CG30417                                     IP01291                                    [BT022172](BT022172)                                    match                                            807                                                           863                                                  804                                                    804
  CG30431\*                                   IP01295                                    [BT022169](BT022169)                                    match                                            1810                                                          1847                                                 1254                                                   1254
  CG30443\*                                   IP01303                                    [BT022170](BT022170)                                    match                                            1771                                                          1801                                                 1686                                                   1686
  CG31241\*                                   IP01327                                    [BT022165](BT022165)                                    match                                            2020                                                          2053                                                 1473                                                   1473
  CG31612\*                                   IP01335                                    [BT022163](BT022163)                                    match                                            3308                                                          3452                                                 2961                                                   2961
  CG32611\*                                   IP08939                                    [BT022126](BT022126)                                    SLIP artifact                                    3313                                                          3001                                                 3309                                                   2136
  CG32705\*                                   IP01380                                    [BT022162](BT022162)                                    5′ short                                         4705                                                          1215                                                 4101                                                   1188
  CG32767\*                                   IP01381                                    [BT022159](BT022159)                                    n.d., frame                                      7670                                                          5378                                                 3843                                                   3672
  CG32772\*                                   IP01388                                    [BT022160](BT022160)                                    exon variant                                     2476                                                          3027                                                 1629                                                   1560
  CG3485                                      IP01409                                    [BT022153](BT022153)                                    intron                                           993                                                           1677                                                 990                                                    N/A
  CG40351\*                                   IP01431                                    [BT022150](BT022150)                                    3′ short                                         5846                                                          2006                                                 4924                                                   1750
  CG4318                                      IP01435                                    [BT022147](BT022147)                                    5′ extension                                     699                                                           1487                                                 696                                                    708
  CG4328                                      IP01440                                    [BT022148](BT022148)                                    n.d., frame                                      1593                                                          1491                                                 1590                                                   816
  CG4565                                      IP01448                                    [BT022145](BT022145)                                    3′ extension                                     672                                                           886                                                  669                                                    825
  CG4676                                      NC                                         N/A                                                     intron                                           1008                                                          N/A                                                  852                                                    N/A
  CG4956                                      IP01459                                    [BT022146](BT022146)                                    5′ extension                                     858                                                           1057                                                 855                                                    906
  CG5245                                      IP01468                                    [BT022143](BT022143)                                    exon variant                                     1506                                                          1542                                                 1503                                                   1422
  CG6118                                      IP09048                                    [BT022124](BT022124)                                    5′ short, u.s.                                   2832                                                          4052                                                 2829                                                   2646
  CG7368                                      IP08855                                    [BT022130](BT022130)                                    match                                            1593                                                          2849                                                 1590                                                   1590
  CG7691                                      IP01563                                    [BT022138](BT022138)                                    match                                            852                                                           1306                                                 849                                                    849
  CG7963                                      NC                                         N/A                                                     co-ligated                                       966                                                           N/A                                                  963                                                    N/A
  CG8089                                      IP01584                                    [BT022135](BT022135)                                    n.d., frame                                      1875                                                          1998                                                 1872                                                   N/A
  CG8117                                      IP08861                                    [BT022128](BT022128)                                    match                                            489                                                           792                                                  486                                                    486
  CG9793                                      IP09168                                    [BT022120](BT022120)                                    intron                                           1041                                                          1227                                                 1038                                                   N/A

^a^Genes represented in our EST collection are indicated by asterisks.

^b^Clone ID numbers for compromised clones that were not fully sequenced are not reported (NC).

^c^Clones that were not fully sequenced were not submitted to GenBank and have no accession numbers (N/A).

^d^Clone classifications relative to the Release 4.1 annotations are indicated. Nucleotide discrepancies (n.d.) are reported with either the corresponding difference in the predicted protein sequence or an indication of a frameshift (n.d., frame). 5′ short clones with upstream in-frame stop codons (5′ short, u.s.), genomic contaminants (genomic), and retained introns (intron) are also indicated by abbreviations. All other classes are reported as described.

^e^Release 4.1 annotated transcript lengths and annotated CDS lengths are reported in nucleotides. For genes with multiple annotated transcripts, the length of the one that most closely matches the cDNA sequence is reported.

^f^cDNA insert and ORF lengths are reported in nucleotides. For clones with unfinished sequences, these data are not known with confidence (N/A). For clones classified as 'co-ligated', 'genomic contaminant' or 'retained intron', ORF lengths are not reported (N/A).

^g^*Rpb4* and *Ada2A* were separate gene annotations in Release 3.1 but are merged into one in Release 4.1. The cDNAs recovered in the two experiments correspond to different Release 4.1 transcript isoforms.
